Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 5/6 |
Past Performance | 2/6 |
Financial Health | 4/6 |
Dividends | 2/6 |
Rewards
Risk Analysis
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥39.18 |
52 Week High | CN¥77.78 |
52 Week Low | CN¥38.90 |
Beta | 0.025 |
11 Month Change | -22.01% |
3 Month Change | -38.28% |
1 Year Change | -36.50% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -61.24% |
Recent News & Updates
Recent updates
Market Cool On Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.'s (SZSE:301096) Earnings Pushing Shares 27% Lower
Jul 24Solid Earnings May Not Tell The Whole Story For Hangzhou Bio-Sincerity Pharma-TechLtd (SZSE:301096)
Apr 29Should You Be Adding Hangzhou Bio-Sincerity Pharma-TechLtd (SZSE:301096) To Your Watchlist Today?
Mar 14Shareholder Returns
301096 | CN Life Sciences | CN Market | |
---|---|---|---|
7D | -8.3% | -4.8% | -0.6% |
1Y | -36.5% | -41.8% | -19.0% |
Return vs Industry: 301096 exceeded the CN Life Sciences industry which returned -41.7% over the past year.
Return vs Market: 301096 underperformed the CN Market which returned -19% over the past year.
Price Volatility
301096 volatility | |
---|---|
301096 Average Weekly Movement | 5.7% |
Life Sciences Industry Average Movement | 5.9% |
Market Average Movement | 5.6% |
10% most volatile stocks in CN Market | 8.9% |
10% least volatile stocks in CN Market | 3.7% |
Stable Share Price: 301096's share price has been volatile over the past 3 months.
Volatility Over Time: 301096's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2011 | 1,747 | Jinfang Lou | www.hzbio-s.com |
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. operates as a pharmaceutical technology research and development and services company in China. The company primarily provides drug research and development services; and the transformation of research and development technology results for various pharmaceutical, as well as pharmaceutical research and development investment companies.
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. Fundamentals Summary
301096 fundamental statistics | |
---|---|
Market cap | CN¥4.24b |
Earnings (TTM) | CN¥286.72m |
Revenue (TTM) | CN¥1.12b |
14.8x
P/E Ratio3.8x
P/S RatioIs 301096 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
301096 income statement (TTM) | |
---|---|
Revenue | CN¥1.12b |
Cost of Revenue | CN¥374.49m |
Gross Profit | CN¥744.16m |
Other Expenses | CN¥457.44m |
Earnings | CN¥286.72m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 2.65 |
Gross Margin | 66.52% |
Net Profit Margin | 25.63% |
Debt/Equity Ratio | 24.1% |
How did 301096 perform over the long term?
See historical performance and comparison